Form 4: Mind Medicine (MindMed) Executive Receives Stock Grant
Insider Transaction (Form 4)
Mark Sullivan, Chief Legal Officer of Mind Medicine (MindMed) Inc., received 62,500 shares of common stock on August 12, 2026.
Summary
- Grant/award: acquired 62,500 Common Shares on August 12, 2026; holds 383,071 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark Sullivan — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Grant/award | Common Shares | 62,500 | — | — | 383,071 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Grant/award (62,500 shares) |
Keywords
insider transaction, Form 4, DFTX, Definium Therapeutics, Inc., neutral, Mark Sullivan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.